$17.35
-0.37 (-2.09%)
Emergent BioSolutions, Inc. (NYSE:EBS)
CAPS Rating:
A biopharmaceutical company focused on the development, manufacture and commercialization of immunobiotics. The Company operates in two business segments: biodefense and commercial.
RSS Headlines
Fool UK